{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:03:18Z","timestamp":1790229798070,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["Z1AHD008735"],"award-info":[{"award-number":["Z1AHD008735"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4127-x","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T13:08:53Z","timestamp":1520946533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Ying","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh-Truc","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziedulla","family":"Abdullaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana D.","family":"Pack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Percy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence R. J.","family":"Lappin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"4127_CR1","first-page":"278","volume-title":"Wintrobe's clinical hematology","author":"JP Greer","year":"2014","unstructured":"Greer JP. Wintrobe's clinical hematology. Thirteenth ed. Philadelphia: Wolters Kluwer, Lippincott Williams & Wilkins Health. xxvii, 2; 2014. p. 278.","edition":"Thirteenth"},{"issue":"9","key":"4127_CR2","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1038\/sj.leu.2404810","volume":"21","author":"A Pardanani","year":"2007","unstructured":"Pardanani A, et al. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia. 2007;21(9):1960\u20133.","journal-title":"Leukemia"},{"issue":"7","key":"4127_CR3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/leu.2008.113","volume":"22","author":"AM Vannucchi","year":"2008","unstructured":"Vannucchi AM, et al. Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal. Leukemia. 2008;22(7):1299\u2013307.","journal-title":"Leukemia"},{"issue":"9464","key":"4127_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054\u201361.","journal-title":"Lancet"},{"issue":"17","key":"4127_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352(17):1779\u201390.","journal-title":"N Engl J Med"},{"issue":"2","key":"4127_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/01.moh.0000154029.05396.d2","volume":"12","author":"JT Prchal","year":"2005","unstructured":"Prchal JT. Polycythemia vera and other primary polycythemias. Curr Opin Hematol. 2005;12(2):112\u20136.","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"4127_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3324\/haematol.2012.070508","volume":"98","author":"NL Tomasic","year":"2013","unstructured":"Tomasic NL, et al. The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). Haematologica. 2013;98(4):560\u20137.","journal-title":"Haematologica"},{"issue":"19","key":"4127_CR8","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2012-11-469296","volume":"121","author":"L Lanikova","year":"2013","unstructured":"Lanikova L, et al. Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer. Blood. 2013;121(19):3918\u201324.","journal-title":"Blood"},{"issue":"13","key":"4127_CR9","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","volume":"31","author":"K Pacak","year":"2013","unstructured":"Pacak K, et al. New syndrome of paraganglioma and somatostatinoma associated with polycythemia. J Clin Oncol. 2013;31(13):1690\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4127_CR10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1073\/pnas.0508423103","volume":"103","author":"MJ Percy","year":"2006","unstructured":"Percy MJ, et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A. 2006;103(3):654\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4127_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMoa073123","volume":"358","author":"MJ Percy","year":"2008","unstructured":"Percy MJ, et al. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med. 2008;358(2):162\u20138.","journal-title":"N Engl J Med"},{"issue":"10","key":"4127_CR12","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJMoa1205119","volume":"367","author":"Z Zhuang","year":"2012","unstructured":"Zhuang Z, et al. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med. 2012;367(10):922\u201330.","journal-title":"N Engl J Med"},{"issue":"1","key":"4127_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","volume":"93","author":"C Yang","year":"2015","unstructured":"Yang C, et al. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia. J Mol Med (Berl). 2015;93(1):93\u2013104.","journal-title":"J Mol Med (Berl)"},{"issue":"25","key":"4127_CR14","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","volume":"359","author":"C Ladroue","year":"2008","unstructured":"Ladroue C, et al. PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med. 2008;359(25):2685\u201392.","journal-title":"N Engl J Med"},{"issue":"1","key":"4127_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3324\/haematol.2011.044644","volume":"97","author":"C Ladroue","year":"2012","unstructured":"Ladroue C, et al. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia. Haematologica. 2012;97(1):9\u201314.","journal-title":"Haematologica"},{"issue":"4","key":"4127_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","volume":"91","author":"FR Lorenzo","year":"2013","unstructured":"Lorenzo FR, et al. A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma. J Mol Med (Berl). 2013;91(4):507\u201312.","journal-title":"J Mol Med (Berl)"},{"issue":"12","key":"4127_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1530\/ERC-16-0231","volume":"23","author":"R Darr","year":"2016","unstructured":"Darr R, et al. Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome. Endocr Relat Cancer. 2016;23(12):899\u2013908.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"4127_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cmet.2013.01.007","volume":"17","author":"SA Anderson","year":"2013","unstructured":"Anderson SA, et al. The IRP1-HIF-2alpha axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metab. 2013;17(2):282\u201390.","journal-title":"Cell Metab"},{"issue":"1","key":"4127_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze MW, et al. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142(1):24\u201338.","journal-title":"Cell"},{"issue":"1","key":"4127_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.str.2005.09.009","volume":"14","author":"J Dupuy","year":"2006","unstructured":"Dupuy J, et al. Crystal structure of human iron regulatory protein 1 as cytosolic aconitase. Structure. 2006;14(1):129\u201339.","journal-title":"Structure"},{"issue":"5807","key":"4127_CR21","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1126\/science.1133116","volume":"314","author":"WE Walden","year":"2006","unstructured":"Walden WE, et al. Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA. Science. 2006;314(5807):1903\u20138.","journal-title":"Science"},{"issue":"9","key":"4127_CR22","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1182\/blood-2013-03-492454","volume":"122","author":"N Wilkinson","year":"2013","unstructured":"Wilkinson N, Pantopoulos K. IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2alpha mRNA translation. Blood. 2013;122(9):1658\u201368.","journal-title":"Blood"},{"issue":"5","key":"4127_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nsmb1222","volume":"14","author":"M Sanchez","year":"2007","unstructured":"Sanchez M, et al. Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency. Nat Struct Mol Biol. 2007;14(5):420\u20136.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"4127_CR24","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.molcel.2008.12.004","volume":"32","author":"M Zimmer","year":"2008","unstructured":"Zimmer M, et al. Small-molecule inhibitors of HIF-2a translation link its 5'UTR iron-responsive element to oxygen sensing. Mol Cell. 2008;32(6):838\u201348.","journal-title":"Mol Cell"},{"issue":"5704","key":"4127_CR25","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1126\/science.1103786","volume":"306","author":"EG Meyron-Holtz","year":"2004","unstructured":"Meyron-Holtz EG, Ghosh MC, Rouault TA. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science. 2004;306(5704):2087\u201390.","journal-title":"Science"},{"issue":"4","key":"4127_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/carcin\/bgl210","volume":"28","author":"G Chen","year":"2007","unstructured":"Chen G, et al. Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts. Carcinogenesis. 2007;28(4):785\u201391.","journal-title":"Carcinogenesis"},{"issue":"4","key":"4127_CR27","doi-asserted-by":"publisher","first-page":"e10163","DOI":"10.1371\/journal.pone.0010163","volume":"5","author":"C Maffettone","year":"2010","unstructured":"Maffettone C, et al. Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert. PLoS One. 2010;5(4):e10163.","journal-title":"PLoS One"},{"issue":"2","key":"4127_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cmet.2012.12.016","volume":"17","author":"MC Ghosh","year":"2013","unstructured":"Ghosh MC, et al. Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2alpha. Cell Metab. 2013;17(2):271\u201381.","journal-title":"Cell Metab"},{"issue":"4","key":"4127_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10689-010-9356-3","volume":"9","author":"XR Yang","year":"2010","unstructured":"Yang XR, et al. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations. Familial Cancer. 2010;9(4):625\u201333.","journal-title":"Familial Cancer"},{"issue":"1","key":"4127_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.blre.2012.12.003","volume":"27","author":"VH Haase","year":"2013","unstructured":"Haase VH. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev. 2013;27(1):41\u201353.","journal-title":"Blood Rev"},{"key":"4127_CR31","first-page":"124","volume":"5","author":"DL Zhang","year":"2014","unstructured":"Zhang DL, Ghosh MC, Rouault TA. The physiological functions of iron regulatory proteins in iron homeostasis - an update. Front Pharmacol. 2014;5:124.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4127_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bcmd.2005.12.006","volume":"36","author":"SR Smith","year":"2006","unstructured":"Smith SR, et al. Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development. Blood Cells Mol Dis. 2006;36(2):283\u20137.","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"4127_CR33","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1182\/blood-2009-05-189985","volume":"114","author":"GL Semenza","year":"2009","unstructured":"Semenza GL. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood. 2009;114(10):2015\u20139.","journal-title":"Blood"},{"issue":"8","key":"4127_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nchembio807","volume":"2","author":"TA Rouault","year":"2006","unstructured":"Rouault TA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol. 2006;2(8):406\u201314.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"4127_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/BJ20101825","volume":"434","author":"J Wang","year":"2011","unstructured":"Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J. 2011;434(3):365\u201381.","journal-title":"Biochem J"},{"issue":"12","key":"4127_CR36","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/j.1460-2075.1995.tb07291.x","volume":"14","author":"K Pantopoulos","year":"1995","unstructured":"Pantopoulos K, Hentze MW. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J. 1995;14(12):2917\u201324.","journal-title":"EMBO J"},{"key":"4127_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fphar.2014.00176","volume":"5","author":"N Wilkinson","year":"2014","unstructured":"Wilkinson N, Pantopoulos K. The IRP\/IRE system in vivo: insights from mouse models. Front Pharmacol. 2014;5:176.","journal-title":"Front Pharmacol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4127-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4127-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4127-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T13:23:05Z","timestamp":1589462585000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4127-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4127"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4127-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"2 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the IRB of the <i>Eunice Kennedy Shriver<\/i> NICHD\/NIH, and the index patient gave written informed consent. Ethical approval reference number is 00CH0093.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient signed the consent form for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"286"}}